Tony is a former managing editor of BRW, Shares, Personal Investor, Asset and CFO magazines. He specialises in small listed companies, IPOs, entrepreneurship and innovation and writes a weekly blog for The Sydney Morning Herald/The Age on small companies and entrepreneurs.
Recent Commentary
6 potential takeover targets
Here’s a snapshot of 3 large-caps and 3 small-caps that have takeover potential. Some have struggled for years while others have rocketed higher than ever.
2 stocks beneficiaries of property boom
There’s a theory that rising property prices boost aged-care providers because higher house-sale prices make it easier for families to afford the Refundable Accommodation Deposit (RAD) for an elderl..
Should you buy or sell our big 4 banks?
Which of the big banks stands out more than the others? And is it time to take profits on bank stocks?
3 emerging markets opportunities
Here are three emerging market ETFs to consider over the next three months.
Are Invocare & Propel worth buying?
As the COVID-19 vaccine is rolled out, funeral restrictions will continue to ease. Higher-margin funeral services will resume, helping the industry to slowly recover over the next few years. Here’s ..
Are Virtus Health & the Monash IVF Group a buy?
The resumption of treatments halted by COVID-19 boosts Virtus Health and Monash IVF Group.
